22-Dec-2025
No headlines found.
15th Annual Spok Survey Highlights Shifting Clinical Communication Opportunities and Obstacles
Business Wire (Wed, 12-Nov 8:30 AM ET)
Spok Reports Third Quarter 2025 Results
Business Wire (Wed, 29-Oct 4:05 PM ET)
Spok Sets Date to Report Third Quarter 2025 Results
Business Wire (Wed, 22-Oct 10:30 AM ET)
U.S. News & World Report Names Spok-Powered Hospitals to Best Children's Hospitals Honor Roll
Business Wire (Thu, 9-Oct 8:30 AM ET)
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Spok Holdings trades on the NASDAQ stock market under the symbol SPOK.
As of December 22, 2025, SPOK stock price climbed to $12.96 with 134,024 million shares trading.
SPOK has a beta of 0.49, meaning it tends to be less sensitive to market movements. SPOK has a correlation of 0.10 to the broad based SPY ETF.
SPOK has a market cap of $266.95 million. This is considered a Small Cap stock.
Last quarter Spok Holdings reported $34 million in Revenue and $.15 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.04.
In the last 3 years, SPOK traded as high as $19.31 and as low as $8.04.
The top ETF exchange traded funds that SPOK belongs to (by Net Assets): VTI, IWM, VXF, IWN, DES.
SPOK has underperformed the market in the last year with a price return of -11.0% while the SPY ETF gained +17.1%. SPOK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.2% and -0.4%, respectively, while the SPY returned +3.0% and +0.5%, respectively.
SPOK support price is $12.74 and resistance is $13.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPOK shares will trade within this expected range on the day.